A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...
Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results